{"id":"https://openalex.org/G9000866296","display_name":"Improving shared decision-making around the use of disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer","description":"NARRATIVE Patients with rheumatoid arthritis (RA) have an increased incidence of cancer, especially lymphoma and lung cancer, compared to the general population and to date relatively little is known about the safety of standard immunosuppressives for RA in patients with active or recently (< 5 years since diagnosis) diagnosed cancer. Little is also known about how to support decision-making for these patients who have at least two major comorbid conditions and may be under the care of multiple different specialists. The central focus of this proposal is to advance the evidence-base around use of immunosuppressive medications among patients with RA who have active or recently diagnosed cancer and to provide a foundation for shared decision making to ensure alignment between treatment decisions and the values, goals, and preferences of individual patients.","funder_award_id":"K23AR079588","funder":{"id":"https://openalex.org/F4320337362","display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi":"https://doi.org/10.13039/100000069"},"funded_outputs":["https://openalex.org/W4296188725","https://openalex.org/W4298086691","https://openalex.org/W4307178186","https://openalex.org/W4313225984","https://openalex.org/W4313488176","https://openalex.org/W4313488273","https://openalex.org/W4315435786","https://openalex.org/W4353096263","https://openalex.org/W4367047781","https://openalex.org/W4376131391","https://openalex.org/W4379648687","https://openalex.org/W4379648699","https://openalex.org/W4385264025","https://openalex.org/W4385997353","https://openalex.org/W4387893822","https://openalex.org/W4390005501","https://openalex.org/W4390059338","https://openalex.org/W4390590694","https://openalex.org/W4392595330","https://openalex.org/W4399856220","https://openalex.org/W4401075132","https://openalex.org/W4401703472","https://openalex.org/W4402653659","https://openalex.org/W4403046712","https://openalex.org/W4403558191","https://openalex.org/W4403825795","https://openalex.org/W4404568173","https://openalex.org/W4404700813","https://openalex.org/W4405414481","https://openalex.org/W4405419332","https://openalex.org/W4406449166","https://openalex.org/W4407388966","https://openalex.org/W4408161440","https://openalex.org/W4409623174","https://openalex.org/W4409792072","https://openalex.org/W4409986424","https://openalex.org/W4410133160","https://openalex.org/W4411045177","https://openalex.org/W4411857779","https://openalex.org/W4412455434","https://openalex.org/W4412521225","https://openalex.org/W4413100380","https://openalex.org/W4416209370","https://openalex.org/W4416239082","https://openalex.org/W4416896368","https://openalex.org/W7124419682","https://openalex.org/W7128390732","https://openalex.org/W7134035797","https://openalex.org/W7154050175","https://openalex.org/W7154694110","https://openalex.org/W7160068476","https://openalex.org/W7161939038","https://openalex.org/W7164036718","https://openalex.org/W7165562854","https://openalex.org/W7170141750","https://openalex.org/W7171222383","https://openalex.org/W7172068888","https://openalex.org/W7203608932","https://openalex.org/W7203671541","https://openalex.org/W7204440577","https://openalex.org/W7211996422","https://openalex.org/W7220980511","https://openalex.org/W7221831451"],"funded_outputs_count":63,"parent_awards":[],"sub_awards":[],"sub_awards_count":0,"amount":null,"currency":"USD","amount_usd":null,"amount_usd_basis":null,"recipients":[],"recipient_countries":[],"recipient_regions":[],"research_scope":{"is_research":true,"basis":"funder_default","tier":1},"funding_type":"career_development","funder_scheme":"K23","start_date":"2022-07-01","end_date":"2027-06-30","start_year":2022,"end_year":2027,"landing_page_url":"https://reporter.nih.gov/project-details/10898084","doi":null,"provenance":"nih_exporter","lead_investigator":{"given_name":"NAMRATA","family_name":"SINGH","orcid":null,"role_start":null,"affiliation":{"name":"UNIVERSITY OF WASHINGTON","country":"UNITED STATES","ids":null},"author":null,"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}]},"co_lead_investigator":null,"investigators":null,"works_api_url":"https://api.openalex.org/works?filter=awards.id:G9000866296","primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.998,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.998,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13026","display_name":"Natural Compounds in Disease Treatment","score":0.0002,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10827","display_name":"Patient-Provider Communication in Healthcare","score":0.0001,"subfield":{"id":"https://openalex.org/subfields/3600","display_name":"General Health Professions"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.963},{"id":"https://openalex.org/keywords/cancer","display_name":"cancer","score":0.67},{"id":"https://openalex.org/keywords/disease-modifying-antirheumatic-drugs","display_name":"disease-modifying antirheumatic drugs","score":0.963},{"id":"https://openalex.org/keywords/shared-decision-making","display_name":"shared decision-making","score":0.844},{"id":"https://openalex.org/keywords/immunosuppressive-drugs","display_name":"immunosuppressants","score":0.794},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.788},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.869},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.996},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.919},{"id":"https://openalex.org/keywords/patient-preferences","display_name":"patient preferences","score":0.629},{"id":"https://openalex.org/keywords/treatment-decision-making","display_name":"treatment decision-making","score":0.592}],"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"institution_awarded":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"updated_date":"2026-11-13T03:01:57.000Z","created_date":"2026-10-09T19:56:01.000Z"}
